D. Western Therapeutics Institute, Inc. (4576.T)
JPY 233.0
(14.22%)
JPY 233.0
(14.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 391.69 Million JPY | -6.86% |
| 2022 | 420.53 Million JPY | 6.65% |
| 2021 | 394.32 Million JPY | 16.47% |
| 2020 | 338.56 Million JPY | -33.68% |
| 2019 | 510.48 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 95.69 Million JPY | -9.24% |
| 2024 Q2 | 96.88 Million JPY | 1.25% |
| 2023 Q4 | 105.43 Million JPY | -6.9% |
| 2023 Q3 | 113.25 Million JPY | 25.35% |
| 2023 Q2 | 90.34 Million JPY | 9.29% |
| 2023 Q1 | 82.66 Million JPY | -30.17% |
| 2023 FY | 391.69 Million JPY | -6.86% |
| 2022 FY | 420.53 Million JPY | 6.65% |
| 2022 Q3 | 81.62 Million JPY | 0.0% |
| 2022 Q4 | 118.37 Million JPY | 45.03% |
| 2021 FY | 394.32 Million JPY | 16.47% |
| 2020 FY | 338.56 Million JPY | -33.68% |
| 2019 FY | 510.48 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 79.179% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -387.757% |
| GNI Group Ltd. | 22.43 Billion JPY | 98.254% |
| Linical Co., Ltd. | 3.77 Billion JPY | 89.633% |
| Trans Genic Inc. | 2.24 Billion JPY | 82.586% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -298.667% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 84.221% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 69.697% |
| AnGes, Inc. | -3.06 Billion JPY | 112.779% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 320.404% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 95.947% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 24.279% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -253.021% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 72.997% |
| CanBas Co., Ltd. | -984 Million JPY | 139.807% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 76.349% |
| Chiome Bioscience Inc. | 398.59 Million JPY | 1.73% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 62.314% |
| PeptiDream Inc. | 17.21 Billion JPY | 97.725% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -1179.85% |
| Ribomic Inc. | -10.5 Million JPY | 3829.747% |
| SanBio Company Limited | -14.5 Million JPY | 2800.621% |
| Healios K.K. | 108 Million JPY | -262.683% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 114967.449% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 763.378% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 26005.952% |
| StemRIM | -44.34 Million JPY | 983.217% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 87.702% |
| FunPep Company Limited | -680.28 Million JPY | 157.578% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -465.629% |
| Stella Pharma Corporation | 217.29 Million JPY | -80.258% |
| TMS Co., Ltd. | -6.95 Million JPY | 5735.942% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -24.522% |
| Cuorips Inc. | 9.63 Million JPY | -3967.054% |
| K Pharma,Inc. | 910 Million JPY | 56.956% |
| Takara Bio Inc. | 25.45 Billion JPY | 98.461% |
| ReproCELL Incorporated | 1.1 Billion JPY | 64.543% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 67.224% |
| StemCell Institute Inc. | 1.57 Billion JPY | 75.144% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 76.5% |
| CellSeed Inc. | 107.15 Million JPY | -265.543% |